IRVINE, Calif.----Allergan, Inc. today announced the United States Food and Drug Administration has approved LUMIGAN® 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Aug
26
Filed Under (Blood Pressure) by Content Keyword RSS
Experts are skeptical of one woman's claim about flies keeping her from home. Recreation - Facebook - Google - Lindsay Lohan - United States
Aug
26
Filed Under (Blood Pressure) by Content Keyword RSS
ST. LOUIS, Aug. 26 (UPI) -- A 2-year-old Missouri boy has become the first person in the United States to be kept alive by a new type of artificial lung, doctors say. United States - Missouri - United Press International - Metro Areas - ST. LOUIS
Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company headquartered in New Jersey, announced that CAMBIA(TM) (diclofenac potassium for oral solution) is now available in the United States for the acute treatment of migraine with or without aura. CAMBIA was approved by the U.S. Food and Drug Administration in June 2009. "The approval and subsequent commercialization ...
Bangalore, Jul 23 : Pharmaceutical and Biotechnology major Wockhardt has received final approval from the United States Food and Drug Administration (USFDA) for marketing 25mg, 50mg, 100mg and 200mg extended-release tablets of Metoprolol succinate, a cardiac drug.